Investment to progress RheumaGen's celiac disease program through early development as a potential transformational gene therapy PHILADELPHIA, Dec. 22, 2025 /PRNewswire/ -- Beyond Celiac Investments ...
A new study published in Gastroenterology has revealed new findings that could help lead to a cure for celiac disease. According to the researchers behind the study, the breakthrough could indeed lead ...
New research presents the results of a trial that used nanoparticles to increase tolerance to gluten in people with celiac disease. People with celiac disease currently have to avoid products that ...
Health on MSN
How Is Celiac Disease Treated?
The main treatment for celiac disease is a strict gluten-free diet. Be careful of medications with gluten, which can worsen ...
Hosted on MSN
Positive proof-of-concept experiments may lead to the world's first treatment for celiac disease
An investigational treatment for celiac disease effectively controls the condition—at least in an animal model—in a first-of-its-kind therapeutic for a condition that affects approximately 70 million ...
The efficacy of a novel therapeutic candidate for celiac disease has been validated at the molecular level, marking an initial step towards the first pharmaceutical intervention for the disease. A ...
Currently, the only treatment for celiac disease is a 100% gluten-free diet. Alice Bast, founder and CEO of Beyond Celiac, points out that 20% of children on the gluten-free diet are not healing, ...
The MarketWatch News Department was not involved in the creation of this content. The growing comprehension of the pathogenesis of celiac disease has paved the way for the exploration of alternative ...
Please provide your email address to receive an email when new articles are posted on . Mean symptom severity and frequency scores improved at 1 year in children identified with celiac disease through ...
Scientists have made a breakthrough that could lead to new treatment options for celiac patients. The team identified how and where the gluten response begins, with certain cells playing a bigger role ...
FDA grants Fast Track designation to Teva's TEV-53408, an anti-IL-15 antibody for celiac disease in Phase 2a study. Teva Pharmaceutical Industries has received Fast Track designation from the FDA for ...
MIAMI — Friday is National Celiac Awareness Day and CBS News Miami sat down with pediatric gastroenterologist Dr. Lina Maria Felipez to discuss what celiac disease is and what symptoms to look out for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results